The most effective means of preventing seasonal influenza is through strain‐specific
vaccination. In this study, we investigated the efficacy, effectiveness and safety of cell‐based …

Background. Adjuvanted vaccines have the potential to improve influenza pandemic
response. AS03 adjuvant has been shown to enhance the immune response to inactivated …

Background A number of enhanced influenza vaccines have been developed for use in
older adults, including high-dose, MF59-adjuvanted, and intradermal vaccines. Methods We …

In preclinical studies, MF59 adjuvant offered improved protection against influenza virus
challenge and significantly reduced the viral load in the lungs of challenged mice. In …

Background During the 2009 influenza A/H1N1 pandemic, adjuvanted influenza vaccines
were used for the first time on a large scale. Results on the effectiveness of the vaccines in …

Elderly people and subjects with underlying chronic diseases are at increased risk for
influenza and related complications. Conventional influenza vaccines provide only limited …

Background Current influenza vaccines, based on antibodies against surface antigens, are
unable to provide protection against newly emerging virus strains which differ from the …

Vaccination represents the most effective intervention to prevent infection, hospitalization
and mortality due to influenza. This meta-analysis quantifies data reporting influenza …

Influenza is a major cause of worldwide morbidity and mortality through frequent seasonal
epidemics and infrequent pandemics. Morbidity and mortality rates from seasonal influenza …

Introduction: Adults at a high risk of severe influenza, because of their age and/or underlying
health disorders, should receive seasonal influenza vaccination in order to reduce the …